Acadia Healthcare Company, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Acadia Healthcare Company, Inc. on October 14, 2020. The filing reports the entry into a material definitive agreement regarding a new debt issuance.
Key Financial Metrics and Transaction Details
- Debt Issuance: $475 million aggregate principal amount of 5.000% Senior Notes due 2029.
- Interest Rate: 5.000% per annum, payable semi-annually in arrears beginning April 15, 2021.
- Maturity Date: April 15, 2029.
- Use of Proceeds: Prepayment of outstanding borrowings under the existing Term Loan B facility (Tranche B-3), general corporate purposes, additional debt repayment, and payment of related fees and expenses.
- Security Status: Senior unsecured obligations, fully and unconditionally guaranteed by the Guarantors.
Material Changes and Covenants
The issuance represents a significant change in the company's capital structure. The Indenture includes covenants that limit the Company's ability to incur additional indebtedness, create liens, pay dividends, purchase capital stock, make restricted payments, sell assets, enter into affiliate transactions, or effect a consolidation or merger. These covenants may be suspended if the Notes achieve an investment-grade rating.
Redemption Terms and Outlook
- Standard Redemption: The Company may redeem the Notes on or after October 15, 2023, at specified redemption prices.
- Equity Redemption: Up to 40% of the Notes may be redeemed prior to October 15, 2023, using net cash proceeds from certain equity offerings at 105.000% of the principal amount.
- Make-Whole Redemption: The Company may redeem some or all Notes prior to October 15, 2023, at 100% of the principal amount plus an applicable "make-whole" premium.
The filing does not provide specific revenue, profit, cash flow, or liquidity metrics for the reporting period, as this is a transaction-specific report rather than a periodic financial statement.
Key Facts for Investor Verification
- Verify the exact amount of the Term Loan B facility (Tranche B-3) being prepaid with the net proceeds.
- Review the full text of the Indenture (Exhibit 4.1) for specific definitions of "investment grade" and the mechanics of covenant suspension.
- Confirm the impact of the new 5.000% interest obligation on the company's future interest coverage ratios.
- Check for any subsequent filings regarding the actual closing of the offering and the final net proceeds received.